Junji Morimoto
Impact in
- Biotechnology top 5%
- Microbial Inactivation Methods
- Toxicology top 5%
Papers in
-
- Angiogenesis and VEGF in Cancer 6
- Genetics 20
- Virus-based gene therapy research 11
- Animal Genetics and Reproduction 4
- Co-authors
- Yoshinori Otsuki (18 shared papers)Masaaki Shibata (20 shared papers)Shunsuke Imai (19 shared papers)Yukihiro Akao (3 shared papers)Munekazu Iinuma (3 shared papers)Eiko Shibata (7 shared papers)Seiichi Suzuki (2 shared papers)Shiro Takahara (2 shared papers)
- Journals
- Cancer Gene Therapy (4 papers)Cancer Letters (4 papers)EXPERIMENTAL ANIMALS (3 papers)International Journal of Cancer (2 papers)The Journal of Gene Medicine (2 papers)
- Partner nations
- JapanUnited StatesNetherlands
In The Last Decade
Junji Morimoto
53 papers receiving 990 citations
Peers
Comparison fields: 5 of 88
- Biotechnology 114
- Toxicology 44
- Oncology 228
- Molecular Biology 562
- Pharmacology 135
Countries citing papers authored by Junji Morimoto
This map shows the geographic impact of Junji Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Morimoto more than expected).
Fields of papers citing papers by Junji Morimoto
This network shows the impact of papers produced by Junji Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Morimoto. The network helps show where Junji Morimoto may publish in the future.
Co-authors
The 25 scholars most cited alongside Junji Morimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. | 2002 | 176 |
| 2 | 2011 | 115 | |
| 3 | COX-2 inhibitor celecoxib suppresses tumor growth and lung metastasis of a murine mammary cancer. | 2007 | 58 |
| 4 | 2002 | 53 | |
| 5 | 2008 | 50 | |
| 6 | Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity. | 2003 | 48 |
| 7 | Panaxanthone isolated from pericarp of Garcinia mangostana L. suppresses tumor growth and metastasis of a mouse model of mammary cancer. | 2009 | 45 |
| 8 | 2007 | 36 | |
| 9 | 2006 | 34 | |
| 10 | 1997 | 30 | |
| 11 | 2005 | 29 | |
| 12 | 1983 | 28 | |
| 13 | 2001 | 24 | |
| 14 | 2002 | 23 | |
| 15 | 1986 | 21 | |
| 16 | An immunocompetent murine model of metastatic mammary cancer accessible to bioluminescence imaging. | 2009 | 20 |
| 17 | 1992 | 19 | |
| 18 | 2010 | 16 | |
| 19 | 2010 | 14 | |
| 20 | 2005 | 11 |
About Junji Morimoto
Junji Morimoto is a scholar working on Molecular Biology, Genetics, Oncology, Immunology and Biotechnology, having authored 55 papers that have together received 1.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (11 papers), Microbial Inactivation Methods (7 papers), Angiogenesis and VEGF in Cancer (6 papers), Cancer Cells and Metastasis (5 papers), Immunotherapy and Immune Responses (5 papers), Lymphatic System and Diseases (5 papers), Animal Genetics and Reproduction (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Biotechnology (114 citations), Toxicology (44 citations), Oncology (228 citations), Molecular Biology (562 citations) and Pharmacology (135 citations). Junji Morimoto has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Yoshinori Otsuki, Masaaki Shibata, Shunsuke Imai, Yukihiro Akao, Munekazu Iinuma, Eiko Shibata, Seiichi Suzuki, Shiro Takahara, Kanako Akamatsu and Yoji Katsuoka. Their work appears in journals such as Cancer Gene Therapy, Cancer Letters, EXPERIMENTAL ANIMALS, International Journal of Cancer and The Journal of Gene Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.